Balyasny Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
Other funds holding SPPI
AC
Balyasny Asset Management's SPPI Position: Q3 2022 in Review
Balyasny Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 29,524 shares — an estimated $23K sold.
Balyasny Asset Management first reported a position in SPPI in Q2 2013 and held it in 12 quarters. The position peaked at $10.6M in Q4 2017. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.
- Balyasny Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
- Balyasny Asset Management sold 29,524 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $23K.
- Balyasny Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
- Balyasny Asset Management's Spectrum Pharmaceuticals Inc position peaked at $10.6M in Q4 2017.
- 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.
Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.